TROMBETTA, Maddalena
 Distribuzione geografica
Continente #
NA - Nord America 4.595
EU - Europa 4.203
AS - Asia 2.782
SA - Sud America 466
AF - Africa 62
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 2
Totale 12.120
Nazione #
US - Stati Uniti d'America 4.498
GB - Regno Unito 1.473
SG - Singapore 1.042
RU - Federazione Russa 935
CN - Cina 925
BR - Brasile 392
IT - Italia 353
SE - Svezia 286
DE - Germania 282
HK - Hong Kong 279
FR - Francia 231
FI - Finlandia 226
IE - Irlanda 199
VN - Vietnam 137
KR - Corea 120
CA - Canada 51
IN - India 47
UA - Ucraina 47
JP - Giappone 43
PK - Pakistan 34
ID - Indonesia 31
MX - Messico 31
NL - Olanda 29
TR - Turchia 28
AR - Argentina 27
AT - Austria 23
BD - Bangladesh 23
PL - Polonia 20
BE - Belgio 18
ZA - Sudafrica 15
EC - Ecuador 14
GR - Grecia 14
ES - Italia 10
IQ - Iraq 10
CZ - Repubblica Ceca 9
UZ - Uzbekistan 9
AU - Australia 8
EG - Egitto 8
DZ - Algeria 7
GH - Ghana 7
PY - Paraguay 7
SA - Arabia Saudita 7
TG - Togo 7
VE - Venezuela 7
MA - Marocco 6
RO - Romania 6
AZ - Azerbaigian 5
CL - Cile 5
CO - Colombia 5
CR - Costa Rica 5
IR - Iran 5
LT - Lituania 5
BG - Bulgaria 4
CH - Svizzera 4
DK - Danimarca 4
JO - Giordania 4
KG - Kirghizistan 4
NO - Norvegia 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
LK - Sri Lanka 3
LV - Lettonia 3
PE - Perù 3
RS - Serbia 3
TH - Thailandia 3
UY - Uruguay 3
AL - Albania 2
IL - Israele 2
JM - Giamaica 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LU - Lussemburgo 2
MD - Moldavia 2
NG - Nigeria 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
AM - Armenia 1
BY - Bielorussia 1
CV - Capo Verde 1
CY - Cipro 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GP - Guadalupe 1
HR - Croazia 1
KE - Kenya 1
KZ - Kazakistan 1
ML - Mali 1
MY - Malesia 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
QA - Qatar 1
Totale 12.112
Città #
Southend 1.336
Dallas 840
Ashburn 558
Chandler 543
Singapore 400
Jacksonville 322
Hong Kong 275
Moscow 251
Woodbridge 234
Beijing 220
Ann Arbor 208
Dublin 199
Houston 157
New York 153
Verona 117
Los Angeles 89
Wilmington 84
Helsinki 79
Lawrence 78
Princeton 78
Jinan 67
Munich 66
Nanjing 54
Seoul 51
Santa Clara 45
Shenyang 45
The Dalles 43
Turku 41
Boardman 39
Dong Ket 36
Buffalo 35
Ho Chi Minh City 35
Redondo Beach 35
Falkenstein 34
Tokyo 34
Milan 30
Sindelfingen 29
São Paulo 29
Hebei 26
Redmond 26
Columbus 24
Zhengzhou 24
Tianjin 23
Frankfurt am Main 22
Jakarta 22
London 22
Nanchang 21
Lancaster 20
Bologna 19
Romola 19
Brussels 18
Phoenix 18
Warsaw 18
Hangzhou 17
Mianwali 17
Nuremberg 17
Rio de Janeiro 17
Council Bluffs 16
Montreal 16
Taiyuan 16
Dearborn 15
Haikou 15
Kent 15
Vienna 15
San Francisco 14
Washington 14
Changsha 13
Redwood City 13
Toronto 13
Hanoi 12
Shanghai 12
Taizhou 12
Atlanta 11
Boston 11
Brasília 11
Brooklyn 11
Dongguan 11
Hyderabad 11
Mexico City 11
Stockholm 11
Denver 10
Guangzhou 10
Jiaxing 10
Seattle 10
Amsterdam 9
Chicago 9
Ningbo 9
Orem 9
Tashkent 9
Ankara 8
Cagliari 8
Manchester 8
Nikaia 8
Poplar 8
Belo Horizonte 7
Bolzano 7
Dhaka 7
Fuzhou 7
Johannesburg 7
Lomé 7
Totale 7.825
Nome #
American Diabetes Association 75th Scientific Meeting - Epidemiology/Genetics Section; Poster 1563-P: Pancreatic Beta-Cell Function, Insulin Sensitivity, and Metabolic Phenotypes in Type 2 Diabetes at the Time of Diagnosis—The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 717
Common Variants Associated to Type 2 Diabetes in the Italian Population 430
"Presence and titer of GAD antibodies are determinants of beta cell function in patients with newly diagnosed type 2 diabetes mellitus: further insights in the metabolic phenotype of LADA patients" 200
Nonalcoholic Fatty Liver Disease Is Independently Associated With an Increased Incidence of Chronic Kidney Disease in Patients With Type 1 Diabetes. 189
Long-Acting GLP-1 Receptor Agonist Exenatide Influence on the Autonomic Cardiac Sympatho-Vagal Balance 175
CACNA1E variants affect beta cell function in patients with newly diagnosed type 2 diabetes. the Verona newly diagnosed type 2 diabetes study (VNDS) 3. 174
A low "genetic load" of risk variants for type 2 diabetes is associated to better beta cell function in patients with newly diagnosed type 2 diabetes 170
Abstracts of 51st EASD Annual Meeting 168
A renal genetic risk score (GRS) is associated with kidney dysfunction in people with type 2 diabetes 165
Association of free-living physical activity measures with metabolic phenotypes in type 2 diabetes at the time of diagnosis. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 162
PPARG2 Pro12Ala and ADAMTS9 rs4607103 as "insulin resistance loci" and "insulin secretion loci" in Italian individuals. The GENFIEV study and the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 4. 157
Differences in the acute effects of aerobic and resistance exercise in subjects with type 2 diabetes: results from the RAED2 randomized trial 156
Assessement of 1th and snd phase of insulin secretion during OGTT and IVGTT 155
Increased aortic stiffness index in patients with type 1 diabetes without cardiovascular disease compared to controls 155
Aerobic and resistence exercise have different short-term effect on glucose levels in type 2 diabetes subject 154
Genetic variability of G6PC2 influences beta cell function and insulin sensitivity in patients with newly diagnosed type 2 diabetes 153
Potential role of MTNR1B locus in regulating beta cell function and glucose levels in patients with newly diagnosed type 2 diabetes 152
Variants and haplotypes of TCF7L2 are associated with beta cell function in patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS).1. 149
Diabetic foot complicated by vertebral osteomyelitis and epidural abscess 149
Prevalence of Cardiovascular Autonomic Neuropathy in a Cohort of Patients With Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 149
Beta-cell function across the spectrum of glucose tolerance in obese youth. 147
Lower levels of 25-hydroxyvitamin D3 are associated with a higher prevalence of microvascular complications in patients with type 2 diabetes. 145
A parsimonious model of a mixed-meal test in patients with type 1 diabetes in insulin pump therapy 145
Association between subclinical left ventricular systolic dysfunction and glycemic control in asymptomatic type 2 diabetic patients with preserved left ventricular function 145
Effects of angiotensin II receptor inhibition on insulin-induced endothelial dysfunction in humans. 145
Relationship of Chronic Vascular Complications with Beta-Cell Dysfunction and Insulin Resistance in Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 143
Confronto delle variazioni acute della glicemia indotte dall'esercizio fisico aerobico o di forza muscolare: studio mediante holter glicemico 142
Body mass index is a potential modifier of the influence on beta cell function exerted by SLC30A8 and KCNJ11 diabetes risk variants in patients with newly diagnosed type 2 diabetes 141
VARIABLES INFLUENCING THE OPTIMAL SAMPLING DURATION OF INTERMITTENTLY-SCANNED CONTINUOUS GLUCOSE MONITORING TO ASSESS 90 DAYS OF GLYCEMIA RISK INDEX. FINDINGS FROM A MULTICENTRIC REAL-WORLD STUDY. 138
Interleukin-6 as a potential positive modulator of human beta-cell function: an exploratory analysis-the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 6 135
Variants in CACNA1E affect beta cell function and glucose homeostasis in newly diagnosed type 2 diabetes patients 134
Chronic complications in patients with newly diagnosed type 2 diabetes: prevalence and related metabolic and clinical features: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 9 133
Confronto degli effetti metabolici dell'esercizio aerobico e dell'esercizio di forza nel diabete tipo 2 132
Is common genetic variation at IRS1, ENPP1 and TRIB3 loci associated with cardiometabolic phenotypes in type 2 diabetes? An exploratory analysis of the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 5 132
Accuracy of CGM Systems During Continuous and Interval Exercise in Adults with Type 1 Diabetes 130
In patients with newly-diagnosed type 2 diabetes beta cell function is an independent predictor of glucose control evolution over 18 months 129
Cutaneous squamous carcinoma in a patient with diabetic foot: an unusual evolution of a frequent complication 128
Haplotypes of the genes (GCK and G6PC2) underlying the glucose/glucose-6-phosphate cycle are associated with pancreatic beta cell glucose sensitivity in patients with newly diagnosed type 2 diabetes from the VNDS study (VNDS 11) 128
Metabolic effects of aerobic training and resistance training in type 2 diabetic subjects: a randomized controlled trial (the RAED2 study). 126
Differences in the acute effects of aerobic and resistance exercise in subjects with type 2 diabetes: Results from the RAED2 randomized trial - Note in: Riddell et al., Physical activity and exercise 126
Impaired Aortic Valve Growth in Type 1 Diabetes Mellitus 126
Insulin sensitivity and beta-cell function: Relationships to glycemic control in newly diagnosed Type 2 diabetic patients 123
Increased prevalence of chronic kidney disease in patients with type 1 diabetes and non-alcoholic fatty liver. 122
Contribution of β-cell dysfunction and insulin resistance to cirrhosis-associated diabetes: Role of severity of liver disease 122
Influence of health locus of control and fear of hypoglycaemia on glycaemic control and treatment satisfaction in people with Type 1 diabetes on insulin pump therapy 121
Growing up with type 1 diabetes mellitus: Data from the Verona Diabetes Transition Project 120
“Genetic Load” of diabetes risk alleles affects beta-cell function in patients with newly diagnosed type 2 diabetes 119
Role of monogenic diabetes genes on beta cell function in Italian patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 13 119
11-6: CONTINUOUS GLUCOSE MONITORING AND ASSESSMENT OF LONG-TERM ISLET FUNCTION IN AUTOLOGOUS ISLET TRANSPLANTATION AFTER TOTAL PANCREATECTOMY FOR PANCREATIC NEOPLASIA: PRELIMINARY DATA FROM THE VERONA COHORT 118
Variants of GCKR affect both beta cell and kidney function in patients with newly diagnosed type 2 diabetes. The Verona Newly diagnosed type diabets study (VNDS). 2. 118
Increased prevalence of cardiovascular disease in type 1 diabetic patients with non-alcoholic fatty liver disease. 117
Relation of serum gamma-glutamyltransferase to atherogenic dyslipidemia and glycemic control in type 2 diabetes. 115
Evidence of left atrial remodeling and left ventricular diastolic dysfunction in type 2 diabetes mellitus with preserved systolic function 115
Evaluating endothelial function of the common carotid artery: An in vivo human model. 114
A longitudinal study of glucose tolerance in cystic fibrosis: the central role of beta cell functional mass 113
Quantitation of the roles played by the main determinants of meal glucose tolerance in patients with type 1 diabetes on insulin pump therapy 113
Left ventricular chamber dilation and filling pressure may help to categorise patients with type 2 diabetes 113
Pathogenetic Mechanisms and Cardiovascular Risk: Differences between HbA1c and oral glucose tolerance test for the diagnosis of glucose tolerance. 112
Glomerular filtration rate decline in T2DM following diagnosis. The Verona newly diagnosed diabetes study-12 109
PPARgamma Pro12Ala and ADAMTS9 rs4607103 are determinants of insulin sensitivity in both non-diabetic and type 2 diabetic Italian subjects 108
Defects in the dynamic control of beta cell function and in glucose effectiveness underly the initial decline in intravenous glucose tolerance of obese European children 108
Relationship between soluble CD40 ligand and gamma-glutamyltransferase concentrations in non-drinking, young type 1 diabetic individuals 105
Continuous subcutaneous insulin infusion in Italy: third national survey. 104
Estimated peak systolic pulmonary artery pressure in young non-complicated patients with type 1 diabetes 103
Review article: type 2 diabetes and chronic liver disease in the Verona Diabetes Study 100
Type 2 Diabetes Mellitus: a Disease of the Governance of the Glucose-Insulin System. An Experimental Metabolic Control Analysis Study. 98
Changes induced by metabolic surgery on the main components of glucose/insulin system in patients with diabetes and obesity 98
Heritability of model-derived parameters of beta cell secretion during intravenous and oral glucose tolerance tests: a study of twins. 96
Uric acid is a biomarker of beta cell function in patients with newly diagnosed type 2 diabetes 96
A sub-analysis of the SAGE study in Italy indicates good glycemic control in type 1 diabetes 94
Metabolic abnormalities underlying the different prediabetic phenotypes in obese adolescents. 93
Metabolic control analysis (MCA) of intravenous glucose tolerance in healthy humans. 93
Insulin sensitivity is correlated with subcutaneous but not visceral body fat in overweight and obese prepubertal children. 93
Central role of the β-cell in driving regression of diabetes after liver transplantation in cirrhotic patients 90
Continuous Glucose Monitoring and Long-Term Assessment of Islet Function in Autologous Islet Transplantation after Total Pancreatectomy for Neoplasm: Preliminary Insights from a Prospective Study 88
Metabolic syndrome in subjects at high risk for type 2 diabetes: the genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study. 88
Echocardiographic parameters according to insulin dose in young patients affected by type 1 diabetes 86
Variability of body weight, pulse pressure and glycemia strongly predict total mortality in elderly type 2 diabetic patients. The Verona Diabetes Study. 85
Methods to assess in vivo insulin sensitivity and insulin secretion 85
Impact of CFTR Modulators on Beta-Cell Function in Children and Young Adults with Cystic Fibrosis 84
A Randomized Crossover Trial Comparing Glucose Control During Postprandial Moderate Aerobic Activity and High-Intensity Interval Training in Adults With Type 1 Diabetes Using an Advanced Hybrid Closed-Loop System 79
Depressive symptoms and glycaemic control in adults with type 1 diabetes: an exploratory study on the role of family functioning 79
SARS-CoV-2 and COVID-19 in diabetes mellitus. Population-based study on ascertained infections, hospital admissions and mortality in an Italian region with ∼5 million inhabitants and ∼250,000 diabetic people 79
Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion 76
Continuous intraperitoneal insulin infusion: an alternative route for insulin delivery in type 1 diabetes 76
Effects of Semaglutide on Glycemic Control and Weight Loss in a Patient with Prader-Willi Syndrome: A Case Report 73
61st EASD Annual Meeting of the European Association for the Study of Diabetes SO 019 It's beta cell replacement time: 402 - Continuous glucose monitoring and assessment of islet function in autologous islet transplantation after total pancreatectomy for pancreatic neoplasia: preliminary data from the Verona cohort 70
Markers of subclinical vascular damage in young adults with type 1 diabetes mellitus: the role of central blood pressure 69
Loss of ZnT8 function protects against diabetes by enhanced insulin secretion 68
Different Times for Different Metrics: Predicting 90 Days of Intermittently Scanned Continuous Glucose Monitoring Data in Subjects With Type 1 Diabetes on Multiple Daily Injection Therapy. Findings From a Multicentric Real-World Study 65
G Protein-Coupled Receptors and the Rise of Type 2 Diabetes in Children 64
Crosstalk between genetic variability of adiponectin and leptin, glucose‐insulin system and subclinical atherosclerosis in patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study 14 63
Interactions of the Osteokines, Glucose/Insulin System and Vascular Risk Networks in Patients With Newly Diagnosed Type 2 Diabetes (VNDS 15) 58
Insulin resistance and beta‐cell dysfunction in newly diagnosed type 2 diabetes: Expression, aggregation and predominance. Verona Newly Diagnosed Type 2 Diabetes Study 10 57
Glucose tolerance stages in Cystic Fibrosis are idenfied by a unique pattern of defects of Beta-cell function 57
61st EASD Annual Meeting of the European Association for the Study of Diabetes SO 077 Hi Hypo :) I would like to know you better 854 - Detecting hypoglycaemia with glycaemia risk index in adults with type 1 diabetes using continuous glucose monitoring and multiple daily injection therapy: a multicentric real-world study 56
Assessing attitudes towards insulin pump therapy in adults with type 1 diabetes: Italian validation of the Insulin Pump Attitudes Questionnaire (IT-IPA questionnaire) 56
Elevated 1-Hour Postload Plasma Glucose Levels Identify Subjects With Normal Glucose Tolerance but Impaired β-Cell Function, Insulin Resistance, and Worse Cardiovascular Risk Profile: The GENFIEV Study. 56
Correction to: Assessing attitudes towards insulin pump therapy in adults with type 1 diabetes: Italian validation of the Insulin Pump Attitudes Questionnaire (IT‑IPA questionnaire) 54
Lower heart rate variability, an index of worse autonomic function, is associated with worse beta cell response to a glycemic load in vivo—The Maastricht Study 50
Totale 12.332
Categoria #
all - tutte 41.433
article - articoli 29.487
book - libri 0
conference - conferenze 11.619
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 327
Totale 82.866


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021489 0 0 0 0 95 80 25 44 59 39 65 82
2021/2022664 82 154 19 55 23 36 13 32 24 18 54 154
2022/20231.427 101 196 120 255 130 323 17 80 139 14 34 18
2023/20241.308 36 61 74 102 100 217 32 308 10 130 164 74
2024/20252.367 96 134 114 449 97 90 152 79 389 137 213 417
2025/20263.280 461 522 774 1.431 92 0 0 0 0 0 0 0
Totale 12.370